Research Thursday. Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of RSV Prevention Products - U.S. Oct 2024-Feb 2025

May 22, 2025

Here is the citation.

Patton ME, Moline HL, Whitaker M, et al. Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products — United States, October 2024–February 2025. MMWR Morb Mortal Wkly Rep 2025;74(16):273-281

Here is the Link. This is an open access article.

Link to article